Report overview
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It?s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is used to describe the acute onset of symptomatic hepatitis. Symptoms include changes I appetite, dry mouth, yellowing of skin or eyes, weight loss, fever and fatigue. Sometime alcoholic hepatitis could get serious conditions include fluid buildup in the abdomen, confusion or brain fog and bleeding in esophagus or stomach. Treatment for alcoholic hepatitis involves therapies and drinking cessation to ease the sign and symptoms of liver damage. Corticosteroids are the current main treatment for alcoholic hepatitis in patients who do not have contraindication for steroid treatment. Corticosteroids are the medications have shown short-term benefits in increasing survival of certain people suffer with alcoholic hepatitis. Pentoxifylline is recommend to patients who can?t take corticosteroids. Studies indicate that pentoxifylline might not be effective for people with mild alcoholic hepatitis or people who have not respond to steroid treatment.
This report aims to provide a comprehensive presentation of the global market for Alcoholic Hepatitis Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alcoholic Hepatitis Therapeutic. This report contains market size and forecasts of Alcoholic Hepatitis Therapeutic in global, including the following market information:
Global Alcoholic Hepatitis Therapeutic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Alcoholic Hepatitis Therapeutic market was valued at US$ 2743.7 million in 2022 and is projected to reach US$ 3866.9 million by 2029, at a CAGR of 5.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global alcoholic hepatitis therapeutics market is expected to witness a favorable growth during the forecast period. Increasing incidence of liver diseases and high success rate of pipeline drugs are the major factors which increase global alcoholic hepatitis market. Moreover high adoption rate for novel therapeutic products and increasing prevalence of alcoholic liver disease are some other factors that are expected to fuel the demand of global alcoholic hepatitis market. Global alcoholic hepatitis market shows potential to be expanding and lucrative field due to increasing merger and acquisitions among pharmaceutical companies to develop advance therapies for treating liver diseases. Furthermore, increased focus on retaining best quality of life is one the factor contributing to the growth of the market. However increasing health care expenditure, stringent reimbursement policies and high development cost are some factors that might hinder the growth of alcoholic hepatitis therapeutics market in forecast period.
We surveyed the Alcoholic Hepatitis Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alcoholic Hepatitis Therapeutic Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Alcoholic Hepatitis Therapeutic Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Caspase Protease Inhibitor
Corticosteroids
Hemorheologic Agents
Anabolic Steroids
Hepatotropic Hormones
Sulfhydryl Agents
Others
Global Alcoholic Hepatitis Therapeutic Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Alcoholic Hepatitis Therapeutic Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Research and Development
Global Alcoholic Hepatitis Therapeutic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Alcoholic Hepatitis Therapeutic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alcoholic Hepatitis Therapeutic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Alcoholic Hepatitis Therapeutic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alkermes
Conatus pharmaceuticals
Dainippon sumitomo pharma
Generon corporation
Immuron limited
Lupin Laboratories
Intercept Pharmaceuticals
Teva Pharmaceuticals
Sanofi-Aventis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Alcoholic Hepatitis Therapeutic, market overview.
Chapter 2: Global Alcoholic Hepatitis Therapeutic market size in revenue.
Chapter 3: Detailed analysis of Alcoholic Hepatitis Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Alcoholic Hepatitis Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
